Leerink Partnrs Has Positive Forecast for RCKT Q2 Earnings
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) – Equities researchers at Leerink Partnrs boosted their Q2 2025 earnings per share (EPS) estimates for Rocket Pharmaceuticals in a report issued on Tuesday, May 27th. Leerink Partnrs analyst M. Foroohar now forecasts that the biotechnology company will post earnings per share of ($0.56) for the quarter, up […]
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) – Equities researchers at Leerink Partnrs boosted their Q2 2025 earnings per share (EPS) estimates for Rocket Pharmaceuticals in a report issued on Tuesday, May 27th. Leerink Partnrs analyst M. Foroohar now forecasts that the biotechnology company will post earnings per share of ($0.56) for the quarter, up […]
